Literature DB >> 1894617

Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement.

K E Brigle1, E H Westin, M T Houghton, I D Goldman.   

Abstract

L1210 murine leukemic cells grown under conditions of continuous low folate concentrations acquire increased levels of a high affinity/low capacity folate-binding protein (FBP). Using an oligonucleotide probe complementary to the human FBP, we have cloned and sequenced two murine FBP cDNAs isolated from a library constructed using a L1210 subline adapted for growth on low levels of 5-formyltetrahydrofolate. The encoding proteins, designated FBP1 and FBP2, have predicted Mr values of 29,415 and 28,821, respectively. These proteins share significant sequence identity with each other (70%) and with the deduced sequences of the human- and bovine-encoded FBPs (68-79%). Southern blot analysis of the low folate-adapted cell line revealed that, while neither of the two FBP-encoding genes was amplified, the FBP1 genomic locus had undergone rearrangement. On Northern blot analysis, this rearrangement was reflected in the enhanced expression (greater than 100-fold) of a FBP1-specific transcript which was 200 nucleotides shorter than the corresponding L1210 parental transcript. The increased expression of this transcript coincided with the increased expression of a membrane protein (Mr = 38,000) which could be affinity-labeled with a N-hydroxysuccinimide ester of [3H]folate. Accordingly, the FBP1 transcript appears to encode the high affinity/low capacity FBP. Compared to parental L1210 cells, expression of the FBP2-encoding transcript was unchanged in this cell line and, while the exact nature of the protein is unclear, FBP2 may represent a fetal form of the FBP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894617

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

2.  Downregulation of reduced-folate transporter by glucose in cultured RPE cells and in RPE of diabetic mice.

Authors:  Hany Naggar; M Shamsul Ola; Pamela Moore; Wei Huang; Christy C Bridges; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

3.  Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites.

Authors:  F Shen; H Wang; X Zheng; M Ratnam
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice.

Authors:  T A Patrick; D M Kranz; T A van Dyke; E J Roy
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

5.  Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Authors:  K N Chung; Y Saikawa; T H Paik; K H Dixon; T Mulligan; K H Cowan; P C Elwood
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium.

Authors:  C A Luhrs; C A Raskin; R Durbin; B Wu; E Sadasivan; W McAllister; S P Rothenberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Novel folate binding protein-1 interactions in embryonic orofacial tissue.

Authors:  M Michele Pisano; Vasker Bhattacherjee; Leeyean Wong; Richard H Finnell; Robert M Greene
Journal:  Life Sci       Date:  2010-01-05       Impact factor: 5.037

8.  Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.

Authors:  D M Kranz; T A Patrick; K E Brigle; M J Spinella; E J Roy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

9.  The folate receptor in central nervous system malignancies of childhood.

Authors:  S D Weitman; K M Frazier; B A Kamen
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing Macrophages.

Authors:  Yuko Furusho; Masaaki Miyata; Takami Matsuyama; Taku Nagai; Hua Li; Yuichi Akasaki; Narisato Hamada; Takahiro Miyauchi; Yoshiyuki Ikeda; Takahiro Shirasawa; Kanako Ide; Chuwa Tei
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.